Select publications

Buzdar AU et al. Significantly higher pathological complete remission rate following neoadjuvant therapy with trastuzumab [Herceptin (H)], paclitaxel (P), and anthracycline-containing chemotherapy: Initial results of a randomized trial in operable breast cancer with HER-2 positive disease. Presentation. ASCO, 2004;Abstract 520.

Boccardo F et al. Anastrozole appears to be superior to tamoxifen in women already receiving adjuvant tamoxifen treatment. Breast Cancer Res Treat 2003;Abstract 3.

Coombes RC et al. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 2004;350(11):1081-92. Abstract

Goss PE et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003;349(19):1793-802. Abstract

Mansel RE et al. Sentinel node biopsy in breast cancer: The first results of the randomized multicenter ALMANAC Trial. Proc ASCO 2004;Abstract 506.

Veronesi U et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349(6):546-53. Abstract